Inspira Awarded $1.98M NIH Grant for Diabetes Therapy
Inspira Therapeutics was awarded a $1.98 million NIH grant to develop its polymeric biomaterial-based tolerogenic treatment for type 1 diabetes.
Anchor Biologics Wins the 2019 Cade Prize
The Cade Museum for Creativity and Invention announced Anchor Biologics as the first place winner of its 2019 Cade Prize. Anchor Biologics is a collaboration of UF biomedical engineering researchers that aim to create a new treatment for inflammatory diseases. The Anchor Biologics team, Dr. Benjamin Keselowsky, professor, and Dr. Gregory Hudalla, assistant professor, accepted […]